Search Results - "Kostoff, Diana"

Video reflexive ethnography as an intervention to improve oral anti-cancer agent patient education: A pilot study by Manojlovich, Milisa, Rizvi-Toner, Amna, DasGupta, Ryan, Farris, Karen, Friese, Chris, Kostoff, Diana, Mackler, Emily, Millisor, Vanessa, Titler, Marita G.

“…Oral anticancer agents (OAAs) are associated with side effects that interfere with medication adherence, despite patient education regarding side effect…”
Get full text

Identifying opportunities to advance practice at a large academic medical center using the ASHP Ambulatory Care Self-Assessment Tool by Martirosov, Amber Lanae, Michael, Angela, McCarty, Melissa, Bacon, Opal, DiLodovico, John R, Jantz, Arin, Kostoff, Diana, MacDonald, Nancy C, Mikulandric, Nancy, Neme, Klodiana, Sulejmani, Nimisha, Summers, Bryant B

“…PURPOSE.The use of the ASHP Ambulatory Care Self-Assessment Tool to advance pharmacy practice at 8 ambulatory care clinics of a large academic medical center…”
Get full text

Implementation of oral chemotherapy management program in the large integrated health care system and its impact on patient safety by Yoo, Jessica, Nhean, Salin, Vogel, Prabha, Rybkin, Igor I., Kostoff, Diana

“…Abstract only 279 Background: Oral chemotherapy is a progressively growing portion of antineoplastic agents. Although convenient for the patient, it creates a…”
Get full text

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications by Belcher, Sarah M, Mackler, Emily, Muluneh, Benyam, Ginex, Pamela K, Anderson, Mary K, Bettencourt, Elizabeth, DasGupta, Ryan K, Elliott, Jennifer, Hall, Erica, Karlin, Michelle, Kostoff, Diana, Marshall, Victoria K, Millisor, Vanessa E, Molnar, Maegan, Schneider, Susan M, Tipton, Janelle, Yackzan, Susan, LeFebvre, Kristine B, Sivakumaran, Kapeena, Waseem, Haya, Morgan, Rebecca L

“…This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral…”
Get full text

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications by Belcher, Sarah M, Mackler, Emily, Muluneh, Benyam, Ginex, Pamela K, Anderson, Mary K, Bettencourt, Elizabeth, DasGupta, Ryan K, Elliott, Jennifer, Hall, Erica, Karlin, Michelle, Kostoff, Diana, Marshall, Victoria K, Millisor, Vanessa E, Molnar, Maegan, Schneider, Susan M, Tipton, Janelle, Yackzan, Susan, LeFebvre, Kristine B, Sivakumaran, Kapeena, Waseem, Haya, Morgan, Rebecca L

“…PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence…”
Get full text

Bortezomib‐Induced Sweet's Syndrome Confirmed by Rechallenge by Zobniw, Chrystia M., Saad, Samira A., Kostoff, Diana, Barthel, Bernd G.

“…Sweet's syndrome, also known as acute febrile neutrophilic dermatosis, is characterized predominantly by fever, elevated neutrophil count, and erythematous…”
Get full text

Improving adherence to the Epic Beacon ambulatory workflow by Chackunkal, Ellen, Dhanapal Vogel, Vishnuprabha, Grycki, Meredith, Kostoff, Diana

“…Computerized physician order entry has been shown to significantly improve chemotherapy safety by reducing the number of prescribing errors. Epic's Beacon…”
Get full text

State affiliate initiative to advance ambulatory care practice by Smith, Amber Lanae, Garwood, Candice L, Bailey, Teresa, DeCator, Devin, Elder, Jodie, Green, Angela, Kostoff, Diana, Lucarotti, Richard L, MacDonald, Nancy C, Malburg, Diane, Ottney, Anne, Remington, Tami L, Shuster, Jesse

Get full text

Bortezomib-Induced Sweet's Syndrome Confirmed by Rechallenge by Zobniw, Chrystia M., Saad, Samira A., Kostoff, Diana, Barthel, Bernd G.

Get full text